BB
OPTR

BB Biotech’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

BB Biotech’s Portfolio OPTR Stock Details OPTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-1,422,200
Closed -$17.9M – 24
2013
Q3 		$17.9M Sell
1,422,200
-24,500
-2% -$325K 0.97% 21
2013
Q2 		$20.9M Buy
+1,446,700
New +$21.1M 1.51% 14

BB Biotech's OPTR Position: Q4 2013 in Review

BB Biotech sold out of OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q4 2013, closing a stake of 1,422,200 shares — an estimated $17.9M sold.

BB Biotech first reported a position in OPTR in Q2 2013 and held it in 2 quarters. The position peaked at $20.9M in Q2 2013. 0 funds tracked by Wall St. Rank hold OPTR as of Q4 2013.

  • BB Biotech reported no remaining OPTIMER PHARMACEUTICALS, INC. COM STK position as of Q4 2013 after selling out during the quarter.
  • BB Biotech sold 1,422,200 OPTIMER PHARMACEUTICALS, INC. COM STK shares in Q4 2013, an estimated $17.9M.
  • BB Biotech first reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK in Q2 2013 and held it in 2 quarters.
  • BB Biotech's OPTIMER PHARMACEUTICALS, INC. COM STK position peaked at $20.9M in Q2 2013.
  • 0 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q4 2013.

Based on BB Biotech's 13F filing for Q4 2013, filed 12 Feb 2014.